The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study

Stroke. 2012 Mar;43(3):623-4. doi: 10.1161/STROKEAHA.111.640557. Epub 2012 Jan 5.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants / adverse effects*
  • Anticoagulants / therapeutic use*
  • Antithrombins / adverse effects*
  • Antithrombins / therapeutic use*
  • Arginine / analogs & derivatives
  • Female
  • Humans
  • Male
  • Pipecolic Acids / adverse effects*
  • Pipecolic Acids / therapeutic use*
  • Stroke / drug therapy*
  • Sulfonamides
  • Tissue Plasminogen Activator / adverse effects*
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Anticoagulants
  • Antithrombins
  • Pipecolic Acids
  • Sulfonamides
  • Arginine
  • Tissue Plasminogen Activator
  • argatroban